newdrugapprovals.org
FDA approves Mylotarg (gemtuzumab ozogamicin) for treatment of acute myeloid leukemia
FDA approves Mylotarg for treatment of acute myeloid leukemia 09/01/2017 The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly…